Biomedical Engineering Reference
In-Depth Information
16. Walter-Coleman S (1996) Transfusion therapy for patients critically ill with cancer. AACN
Clin Issues 7:37-45
17. Roback JD, Hillyer CD (2001) Platelets and related products. In: Hillyer KL, Strobl F, Hillyer
CD et al (eds) Handbook of transfusion medicine. Academic, New York, pp 53-61
18. Craig V, Bower JO (1997) Blood administration in perioperative settings. AORN J
66:133-43
19. Balint B, Vucetic D, Trajkovic-Lakic Z et al (2002) Quantitative, functional, morphological
and ultrastructural recovery of platelets as predictor for cryopreservation efficacy. Hematologia
32(4):363-76
20. Balint B (2003) The function and therapeutic use of platelets and their alternatives. Vojnosanit
Pregl 60:43-51
21. Murphy M (2000) Trigger factors for prophylactic platelet transfusions. In: Seghatchian J,
Snyder EL, Krailadsiri P (eds) Platelet therapy. Current status and future trends. Elsevier,
New York, pp 467-83
22. Consensus Conference on Platelet Transfusion (1998) Synopsis of background papers and
consensus statement. Br J Hematol 101:609-17
23. Rebulla P (2000) Trigger for platelet transfusion. Vox Sang 78(Suppl 2):179-82
24. Wandt H, Frank M, Ehninger G et al (1998) Safety and cost effectiveness of a 10x10
9
/L trigger
for prophylactic platelet transfusions compared with the traditional 20x10
9
/L trigger: a pro-
spective comparative trial in 105 patients with acute myeloid leukaemia. Blood 91:3601-6
25. Brecher ME (2002) Technical manual, 14th edn. American Association of Blood Banks,
Bethesda
26. Vucetic D, Balint B, Taseski J et al (2000) Quantification and investigation of morphology,
ultra-structure and functional activity of platelets cryopreserved using six freezing protocols.
Bullet Transfusiol 46:19-26
27. Balint B, Lj C, Taseski J et al (2002) The effect of leukoreduction on the proinflamatory
cytokine concentration in platelet concentrates. Bull Transfusiol 48:6-15
28. Balint B, Radovic M, Paunovic D et al (1996) Examination of immune-inflammatory cytok-
ines IL-6, IL-8 and TNF in platelet concentrates. Anest Reanim Transfusiol 25:39-43
29. Milenkovic L, Balint B, Skaro-Milic A et al (1995) Recovery and morphology of platelets
prepared from buffy coat. Vojnosanit Pregl 52:18-24
30. Bucur SZ, Hillyer CD (2001) Fresh frozen plasma and related products. In: Hillyer KL, Strobl
F, Hillyer CD et al (eds) Handbook of transfusion medicine. Academic, New York, pp 39-45
31. Bucur SZ, Hillyer CD (2001) Cryoprecipitate and related products. In: Hillyer KL, Strobl F,
Hillyer CD et al (eds) Handbook of transfusion medicine. Academic, New York, pp 47-51
32. Balint B, Cernak I, Petakov M et al (2002) The use of single-donor fibrin glue prepared by
recycled cryoprecipitation in experimental liver surgery. Haematologia (Budap)
32(2):135-46
33. Strauss RG (2003) Rebirth of granulocyte transfusions: should it involve pediatric oncology
and transfusion reactions. In: Balint B (ed) Transfusion medicine. CTCI-Press, Belgrade, pp
807-48
34. Bharucha ZS (2001) Safe blood transfusion practices. Indian J Pediatr 68:127-31
35. Strauss RG (1999) Rebirth of granulocyte transfusions: should it involve pediatric oncology
and transplant patients? J Pediatr Hematol Oncol 21:475-8
36. Higgins C (1994) Blood transfusion: risks and bene fi ts. Br J Nurs 3:986-91
